Unlock the Insights: Dive into the Comprehensive COVID-19 Dataset and Uncover Key Patterns, Trends, and Impacts Worldwide. Empower Your Analysis with Rich, Reliable, and Up-to-Date Data.

The COVID-19 dataset provides a comprehensive collection of information related to the global pandemic. It encompasses various aspects such as the number of cases, deaths, recoveries, testing, and more. The dataset serves as a valuable resource for researchers, analysts, and individuals seeking to understand the impact and spread of the virus.

The dataset is compiled from reputable sources, including official government reports, health organizations, and reliable data repositories. It ensures the accuracy and reliability of the information, making it a trusted source for COVID-19 data analysis.

The dataset is inspired by the need for reliable and up-to-date information about the COVID-19 pandemic. It aims to provide a comprehensive resource that enables researchers, analysts, and individuals to gain insights, track trends, and make data-driven decisions to combat the global health crisis.

By leveraging this dataset, users can gain a deeper understanding of the pandemic's progression, identify patterns, and contribute to the ongoing efforts in managing and mitigating the impact of COVID-19.

Context

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus. Most people infected with COVID-19 virus will experience mild to moderate respiratory illness and recover without requiring special treatment. Older people, and those with underlying medical problems like cardiovascular disease, diabetes, chronic respiratory disease, and cancer are more likely to develop serious illness. During the entire course of the pandemic, one of the main problems that healthcare providers have faced is the shortage of medical resources and a proper plan to efficiently distribute them. In these tough times, being able to predict what kind of resource an individual might require at the time of being tested positive or even before that will be of immense help to the authorities as they would be able to procure and arrange for the resources necessary to save the life of that patient.

The main goal of this project is to build a machine learning model that, given a Covid-19 patient's current symptom, status, and medical history, will predict whether the patient is in high risk or not.

content

The dataset was provided by the Mexican government (link). This dataset contains an enormous number of anonymized patient-related information including pre-conditions. The raw dataset consists of 21 unique features and 1,048,576 unique patients. In the Boolean features, 1 means "yes" and 2 means "no". values as 97 and 99 are missing data.

• sex: 1 for female and 2 for male.
• age: of the patient.
• classification: covid test findings. Values 1-3 mean that the patient was diagnosed with covid in different degrees. 4 or higher means that the patient is not a carrier of covid or that the test is inconclusive.
• patient type: type of care the patient received in the unit. 1 for returned home and 2 for hospitalization.
• pneumonia: whether the patient already have air sacs inflammation or not.
• pregnancy: whether the patient is pregnant or not.
• diabetes: whether the patient has diabetes or not.
• copd: Indicates whether the patient has Chronic obstructive pulmonary disease or not.
• asthma: whether the patient has asthma or not.
• inmsupr: whether the patient is immunosuppressed or not.
• hypertension: whether the patient has hypertension or not.
• cardiovascular: whether the patient has heart or blood vessels related disease.
• renal chronic: whether the patient has chronic renal disease or not.
• other disease: whether the patient has other disease or not.
• obesity: whether the patient is obese or not.
• tobacco: whether the patient is a tobacco user.
• usmr: Indicates whether the patient treated medical units of the first, second or third level.
• medical unit: type of institution of the National Health System that provided the care.
• intubed: whether the patient was connected to the ventilator.
• icu: Indicates whether the patient had been admitted to an Intensive Care Unit.
• date died: If the patient died indicate the date of death, and 9999-99-99 otherwise.

COVID-19 Global Case and Death Data

Global COVID-19 Cases and Deaths Over Time

By Coronavirus (COVID-19) Data Hub [source]

About this dataset

The COVID-19 Global Time Series Case and Death Data is a comprehensive collection of global COVID-19 case and death information recorded over time. This dataset includes data from various sources such as JHU CSSE COVID-19 Data and The New York Times.

The dataset consists of several columns providing detailed information on different aspects of the COVID-19 situation. The COUNTRY_SHORT_NAME column represents the short name of the country where the data is recorded, while the Data_Source column indicates the source from which the data was obtained.

Other important columns include Cases, which denotes the number of COVID-19 cases reported, and Difference, which indicates the difference in case numbers compared to the previous day. Additionally, there are columns such as CONTINENT_NAME, DATA_SOURCE_NAME, COUNTRY_ALPHA_3_CODE, COUNTRY_ALPHA_2_CODE that provide additional details about countries and continents.

Furthermore, this dataset also includes information on deaths related to COVID-19. The column PEOPLE_DEATH_NEW_COUNT shows the number of new deaths reported on a specific date.

To provide more context to the data, certain columns offer demographic details about locations. For instance, Population_Count provides population counts for different areas. Moreover,**FIPS** code is available for provincial/state regions for identification purposes.

It is important to note that this dataset covers both confirmed cases (Case_Type: confirmed) as well as probable cases (Case_Type: probable). These classifications help differentiate between various types of COVID-19 infections.

Overall, this dataset offers a comprehensive picture of global COVID-19 situations by providing accurate and up-to-date information on cases, deaths, demographic details like population count or FIPS code), source references (such as JHU CSSE or NY Times), geographical information (country names coded with ALPHA codes) , etcetera making it useful for researchers studying patterns and trends associated with this pandemic

How to use the dataset

• Understanding the Dataset Structure:

  • The dataset is available in two files: COVID-19 Activity.csv and COVID-19 Cases.csv.
  • Both files contain different columns that provide information about the COVID-19 cases and deaths.
  • Some important columns to look out for are: a. PEOPLE_POSITIVE_CASES_COUNT: The total number of confirmed positive COVID-19 cases. b. COUNTY_NAME: The name of the county where the data is recorded. c. PROVINCE_STATE_NAME: The name of the province or state where the data is recorded. d. REPORT_DATE: The date when the data was reported. e. CONTINENT_NAME: The name of the continent where the data is recorded. f. DATA_SOURCE_NAME: The name of the data source. g. PEOPLE_DEATH_NEW_COUNT: The number of new deaths reported on a specific date. h.COUNTRY_ALPHA_3_CODE :The three-letter alpha code represents country f.Lat,Long :latitude and longitude coordinates represent location i.Country_Region or COUNTRY_SHORT_NAME:The country or region where cases were reported.

• Choosing Relevant Columns: It's important to determine which columns are relevant to your analysis or research question before proceeding with further analysis.

• Exploring Data Patterns: Use various statistical techniques like summarizing statistics, creating visualizations (e.g., bar charts, line graphs), etc., to explore patterns in different variables over time or across regions/countries.

• Filtering Data: You can filter your dataset based on specific criteria using column(s) such as COUNTRY_SHORT_NAME, CONTINENT_NAME, or PROVINCE_STATE_NAME to focus on specific countries, continents, or regions of interest.

• Combining Data: You can combine data from different sources (e.g., COVID-19 cases and deaths) to perform advanced analysis or create insightful visualizations.

• Analyzing Trends: Use the dataset to analyze and identify trends in COVID-19 cases and deaths over time. You can examine factors such as population count, testing count, hospitalization count, etc., to gain deeper insights into the impact of the virus.

• Comparing Countries/Regions: Compare COVID-19

Research Ideas

• Trend Analysis: This dataset can be used to analyze and track the trends of COVID-19 cases and deaths over time. It provides comprehensive global data, allowing researchers and po...

Public health-related decision-making on policies aimed at controlling the COVID-19 pandemic outbreak depends on complex epidemiological models that are compelled to be robust and use all relevant available data. This data article provides a new combined worldwide COVID-19 dataset obtained from official data sources with improved systematic measurement errors and a dedicated dashboard for online data visualization and summary. The dataset adds new measures and attributes to the normal attributes of official data sources, such as daily mortality, and fatality rates. We used comparative statistical analysis to evaluate the measurement errors of COVID-19 official data collections from the Chinese Center for Disease Control and Prevention (Chinese CDC), World Health Organization (WHO) and European Centre for Disease Prevention and Control (ECDC). The data is collected by using text mining techniques and reviewing pdf reports, metadata, and reference data. The combined dataset includes complete spatial data such as countries area, international number of countries, Alpha-2 code, Alpha-3 code, latitude, longitude, and some additional attributes such as population. The improved dataset benefits from major corrections on the referenced data sets and official reports such as adjustments in the reporting dates, which suffered from a one to two days lag, removing negative values, detecting unreasonable changes in historical data in new reports and corrections on systematic measurement errors, which have been increasing as the pandemic outbreak spreads and more countries contribute data for the official repositories. Additionally, the root mean square error of attributes in the paired comparison of datasets was used to identify the main data problems. The data for China is presented separately and in more detail, and it has been extracted from the attached reports available on the main page of the CCDC website. This dataset is a comprehensive and reliable source of worldwide COVID-19 data that can be used in epidemiological models assessing the magnitude and timeline for confirmed cases, long-term predictions of deaths or hospital utilization, the effects of quarantine, stay-at-home orders and other social distancing measures, the pandemic’s turning point or in economic and social impact analysis, helping to inform national and local authorities on how to implement an adaptive response approach to re-opening the economy, re-open schools, alleviate business and social distancing restrictions, design economic programs or allow sports events to resume.

Earlier this year, Dr. Hoffman and Dr. Fafard published a book chapter on the efficacy and legality of border closures enacted by governments in response to changing COVID-19 conditions. The authors concluded border closures are at best, regarded as powerful symbolic acts taken by governments to show they are acting forcefully, even if the actions lack an epidemiological impact and breach international law. This COVID-19 travel restriction project was developed out of a necessity and desire to further examine the empirical implications of border closures. The current dataset contains bilateral travel restriction information on the status of 179 countries between 1 January 2020 and 8 June 2020. The data was extracted from the ‘international controls’ column from the Oxford COVID-19 Government Response Tracker (OxCGRT). The data in the ‘international controls’ column outlined a country’s change in border control status, as a response to COVID-19 conditions. Accompanying source links were further verified through random selection and comparison with external news sources. Greater weight is given to official national government sources, then to provincial and municipal news-affiliated agencies. The database is presented in matrix form for each country-pair and date. Subsequently, each cell is represented by datum Xdmn and indicates the border closure status on date d by country m on country n. The coding is as follows: no border closure (code = 0), targeted border closure (= 1), and a total border closure (= 99). The dataset provides further details in the ‘notes’ column if the type of closure is a modified form of a targeted closure, either as a land or port closure, flight or visa suspension, or a re-opening of borders to select countries. Visa suspensions and closure of land borders were coded separately as de facto border closures and analyzed as targeted border closures in quantitative analyses. The file titled ‘BTR Supplementary Information’ covers a multitude of supplemental details to the database. The various tabs cover the following: 1) Codebook: variable name, format, source links, and description; 2) Sources, Access dates: dates of access for the individual source links with additional notes; 3) Country groups: breakdown of EEA, EU, SADC, Schengen groups with source links; 4) Newly added sources: for missing countries with a population greater than 1 million (meeting the inclusion criteria), relevant news sources were added for analysis; 5) Corrections: external news sources correcting for errors in the coding of international controls retrieved from the OxCGRT dataset. At the time of our study inception, there was no existing dataset which recorded the bilateral decisions of travel restrictions between countries. We hope this dataset will be useful in the study of the impact of border closures in the COVID-19 pandemic and widen the capabilities of studying border closures on a global scale, due to its interconnected nature and impact, rather than being limited in analysis to a single country or region only. Statement of contributions: Data entry and verification was performed mainly by GL, with assistance from MJP and RN. MP and IW provided further data verification on the nine countries purposively selected for the exploratory analysis of political decision-making.

After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at COVID Data Tracker Hospitalizations. The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Sunday to Saturday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities. The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities. For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-15 means the average/sum/coverage of the elements captured from that given facility starting and including Sunday, November 15, 2020, and ending and including reports for Saturday, November 21, 2020. Reported elements include an append of either “_coverage”, “_sum”, or “_avg”. A “_coverage” append denotes how many times the facility reported that element during that collection week. A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week. A “_avg” append is the average of the reports provided for that facility for that element during that collection week. The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”. A story page was created to display both corrected and raw datasets and can be accessed at this link: https://healthdata.gov/stories/s/nhgk-5gpv This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020. Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect. For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied. For recent updates to the dataset, scroll to the bottom of the dataset description. On May 3, 2021, the following fields have been added to this data set. hhs_ids previous_day_admission_adult_covid_confirmed_7_day_coverage previous_day_admission_pediatric_covid_confirmed_7_day_coverage previous_day_admission_adult_covid_suspected_7_day_coverage previous_day_admission_pediatric_covid_suspected_7_day_coverage previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum total_personnel_covid_vaccinated_doses_none_7_day_sum total_personnel_covid_vaccinated_doses_one_7_day_sum total_personnel_covid_vaccinated_doses_all_7_day_sum previous_week_patients_covid_vaccinated_doses_one_7_day_sum previous_week_patients_covid_vaccinated_doses_all_

Context:

From World Health Organization - On 31 December 2019, WHO was alerted to several cases of pneumonia in Wuhan City, Hubei Province of China. The virus did not match any other known virus. This raised concern because when a virus is new, we do not know how it affects people.

So daily level information on the affected people can give some interesting insights when it is made available to the broader data science community.

Johns Hopkins University has made an excellent dashboard using the affected cases data. Data is extracted from the google sheets associated and made available here.

Edited:

Now data is available as csv files in the Johns Hopkins Github repository. Please refer to the github repository for the Terms of Use details. Uploading it here for using it in Kaggle kernels and getting insights from the broader DS community.

Content

2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. Early on, many of the patients in the outbreak in Wuhan, China reportedly had some link to a large seafood and animal market, suggesting animal-to-person spread. However, a growing number of patients reportedly have not had exposure to animal markets, indicating person-to-person spread is occurring. At this time, it’s unclear how easily or sustainably this virus is spreading between people - CDC

This dataset has daily level information on the number of affected cases, deaths and recovery from 2019 novel coronavirus. Please note that this is a time series data and so the number of cases on any given day is the cumulative number.

The data is available from 22 Jan, 2020.

Here’s a polished version suitable for a professional Kaggle dataset description:

Dataset Description

This dataset contains time-series and case-level records of the COVID-19 pandemic. The primary file is covid_19_data.csv, with supporting files for earlier records and individual-level line list data.

Files and Columns

1. covid_19_data.csv (Main File)

This is the primary dataset and contains aggregated COVID-19 statistics by location and date.

• Sno – Serial number of the record
• ObservationDate – Date of the observation (MM/DD/YYYY)
• Province/State – Province or state of the observation (may be missing for some entries)
• Country/Region – Country of the observation
• Last Update – Timestamp (UTC) when the record was last updated (not standardized, requires cleaning before use)
• Confirmed – Cumulative number of confirmed cases on that date
• Deaths – Cumulative number of deaths on that date
• Recovered – Cumulative number of recoveries on that date

2. 2019_ncov_data.csv (Legacy File)

This file contains earlier COVID-19 records. It is no longer updated and is provided only for historical reference. For current analysis, please use covid_19_data.csv.

3. COVID_open_line_list_data.csv

This file provides individual-level case information, obtained from an open data source. It includes patient demographics, travel history, and case outcomes.

4. COVID19_line_list_data.csv

Another individual-level case dataset, also obtained from public sources, with detailed patient-level information useful for micro-level epidemiological analysis.

✅ Use covid_19_data.csv for up-to-date aggregated global trends.

✅ Use the line list datasets for detailed, individual-level case analysis.

Country level datasets:

If you are interested in knowing country level data, please refer to the following Kaggle datasets:

India - https://www.kaggle.com/sudalairajkumar/covid19-in-india

South Korea - https://www.kaggle.com/kimjihoo/coronavirusdataset

Italy - https://www.kaggle.com/sudalairajkumar/covid19-in-italy

Brazil - https://www.kaggle.com/unanimad/corona-virus-brazil

USA - https://www.kaggle.com/sudalairajkumar/covid19-in-usa

Switzerland - https://www.kaggle.com/daenuprobst/covid19-cases-switzerland

Indonesia - https://www.kaggle.com/ardisragen/indonesia-coronavirus-cases

Acknowledgements :

Johns Hopkins University for making the data available for educational and academic research purposes

MoBS lab - https://www.mobs-lab.org/2019ncov.html

World Health Organization (WHO): https://www.who.int/

DXY.cn. Pneumonia. 2020. http://3g.dxy.cn/newh5/view/pneumonia.

BNO News: https://bnonews.com/index.php/2020/02/the-latest-coronavirus-cases/

National Health Commission of the People’s Republic of China (NHC): http://www.nhc.gov.cn/xcs/yqtb/list_gzbd.shtml

China CDC (CCDC): http://weekly.chinacdc.cn/news/TrackingtheEpidemic.htm

Hong Kong Department of Health: https://www.chp.gov.hk/en/features/102465.html

Macau Government: https://www.ssm.gov.mo/portal/

Taiwan CDC: https://sites.google....

The "COVID-19 Reported Patient Impact and Hospital Capacity by Facility" dataset from the U.S. Department of Health & Human Services, filtered for Connecticut. View the full dataset and detailed metadata here: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/anag-cw7u The following dataset provides facility-level data for hospital utilization aggregated on a weekly basis (Friday to Thursday). These are derived from reports with facility-level granularity across two main sources: (1) HHS TeleTracking, and (2) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities. The hospital population includes all hospitals registered with Centers for Medicare & Medicaid Services (CMS) as of June 1, 2020. It includes non-CMS hospitals that have reported since July 15, 2020. It does not include psychiatric, rehabilitation, Indian Health Service (IHS) facilities, U.S. Department of Veterans Affairs (VA) facilities, Defense Health Agency (DHA) facilities, and religious non-medical facilities. For a given entry, the term “collection_week” signifies the start of the period that is aggregated. For example, a “collection_week” of 2020-11-20 means the average/sum/coverage of the elements captured from that given facility starting and including Friday, November 20, 2020, and ending and including reports for Thursday, November 26, 2020. Reported elements include an append of either “_coverage”, “_sum”, or “_avg”. A “_coverage” append denotes how many times the facility reported that element during that collection week. A “_sum” append denotes the sum of the reports provided for that facility for that element during that collection week. A “_avg” append is the average of the reports provided for that facility for that element during that collection week. The file will be updated weekly. No statistical analysis is applied to impute non-response. For averages, calculations are based on the number of values collected for a given hospital in that collection week. Suppression is applied to the file for sums and averages less than four (4). In these cases, the field will be replaced with “-999,999”. This data is preliminary and subject to change as more data become available. Data is available starting on July 31, 2020. Sometimes, reports for a given facility will be provided to both HHS TeleTracking and HHS Protect. When this occurs, to ensure that there are not duplicate reports, deduplication is applied according to prioritization rules within HHS Protect. For influenza fields listed in the file, the current HHS guidance marks these fields as optional. As a result, coverage of these elements are varied. On May 3, 2021, the following fields have been added to this data set. hhs_ids previous_day_admission_adult_covid_confirmed_7_day_coverage previous_day_admission_pediatric_covid_confirmed_7_day_coverage previous_day_admission_adult_covid_suspected_7_day_coverage previous_day_admission_pediatric_covid_suspected_7_day_coverage previous_week_personnel_covid_vaccinated_doses_administered_7_day_sum total_personnel_covid_vaccinated_doses_none_7_day_sum total_personnel_covid_vaccinated_doses_one_7_day_sum total_personnel_covid_vaccinated_doses_all_7_day_sum previous_week_patients_covid_vaccinated_doses_one_7_day_sum previous_week_patients_covid_vaccinated_doses_all_7_day_sum On May 8, 2021, this data set has been converted to a corrected data set. The corrections applied to this data set are to smooth out data anomalies caused by keyed in data errors. To help determine which records have had corrections made to it. An additional Boolean field called is_corrected has been added. To see the numbers as reported by the facilities, go to: https://healthdata.gov/Hospital/COVID-19-Reported-Patient-Impact-and-Hospital-Capa/uqq2-txqb On May 13, 2021 Changed vaccination fields from sum to max or min fields. This reflects the maximum or minimum number report

About Dataset: WHO COVID-19 Global Data

This dataset provides comprehensive information on the global COVID-19 pandemic as reported to the World Health Organization (WHO). The dataset is available in comma-separated values (CSV) format and includes the following fields:

Daily cases and deaths by date reported to WHO: WHO-COVID-19-global-data.csv

• Date_reported (Date): The date of reporting to WHO.
• Country_code (String): The ISO Alpha-2 country code.
• Country (String): The name of the country, territory, or area.
• WHO_region (String): The WHO regional office to which the country belongs. WHO Member States are grouped into six WHO regions, including AFRO (Regional Office for Africa), AMRO (Regional Office for the Americas), SEARO (Regional Office for South-East Asia), EURO (Regional Office for Europe), EMRO (Regional Office for the Eastern Mediterranean), and WPRO (Regional Office for the Western Pacific).
• New_cases (Integer): The number of new confirmed cases reported on a given day. This is calculated by subtracting the previous cumulative case count from the current cumulative case count.
• Cumulative_cases (Integer): The total cumulative confirmed cases reported to WHO up to the specified date.
• New_deaths (Integer): The number of new confirmed deaths reported on a given day. Similar to new cases, this is calculated by subtracting the previous cumulative death count from the current cumulative death count.- Cumulative_deaths (Integer): The total cumulative confirmed deaths reported to WHO up to the specified date.

In addition to the COVID-19 case and death data, this dataset also includes valuable information related to COVID-19 vaccinations. The vaccination data consists of the following fields:

Vaccination Data Fields: vaccination-data.csv

• COUNTRY (String): Country, territory, or area.
• ISO3 (String): ISO Alpha-3 country code.
• WHO_REGION (String): The WHO regional office to which the country belongs.
• DATA_SOURCE (String): Indicates the data source, which can be either "REPORTING" (Data reported by Member States or sourced from official reports) or "OWID" (Data sourced from Our World in Data COVID-19 Vaccinations).
• DATE_UPDATED (Date): Date of the last update.
• TOTAL_VACCINATIONS (Integer): Cumulative total vaccine doses administered.
• PERSONS_VACCINATED_1PLUS_DOSE (Decimal): Cumulative number of persons vaccinated with at least one dose.
• TOTAL_VACCINATIONS_PER100 (Integer): Cumulative total vaccine doses administered per 100 population.
• PERSONS_VACCINATED_1PLUS_DOSE_PER100 (Decimal): Cumulative persons vaccinated with at least one dose per 100 population.
• PERSONS_LAST_DOSE (Integer): Cumulative number of persons vaccinated with a complete primary series.
• PERSONS_LAST_DOSE_PER100 (Decimal): Cumulative number of persons vaccinated with a complete primary series per 100 population.
• VACCINES_USED (String): Combined short name of the vaccine in the format "Company - Product name."
• FIRST_VACCINE_DATE (Date): Date of the first vaccinations, equivalent to the start/launch date of the first vaccine administered in a country.
• NUMBER_VACCINES_TYPES_USED (Integer): Number of vaccine types used per country, territory, or area.
• PERSONS_BOOSTER_ADD_DOSE (Integer): Cumulative number of persons vaccinated with at least one booster or additional dose.
• PERSONS_BOOSTER_ADD_DOSE_PER100 (Decimal): Cumulative number of persons vaccinated with at least one booster or additional dose per 100 population.

In addition to the vaccination data, a separate dataset containing vaccination metadata is available, including information about vaccine names, product names, company names, authorization dates, start and end dates of vaccine rollout, and more.

Vaccination metadata Fields: vaccination-metadata.csv

• ISO3 (String): ISO Alpha-3 country code
• VACCINE_NAME (String): Combined short name of vaccine: "Company - Product name" (see below)
• PRODUCT_NAME (String): Name or label of vaccine product, or type of vaccine (if unnamed).
• COMPANY_NAME (String): Marketing authorization holder of vaccine product.
• FIRST_VACCINE_DATE (Date): Date of first vaccinations. Equivalent to start/launch date of the first vaccine administered in a country.
• AUTHORIZATION_DATE (Date): Date vaccine product was authorized for use in the country, territory, area.
• START_DATE (Date): Start/launch date of vaccination with vaccine type (excludes vaccinations during clinical trials).
• END_DATE (Date): End date of vaccine rollout
• COMMENT (String): Comments related to vaccine rollout
• DATA_SOURCE (String): Indicates data source - REPORTING: Data reported by Member States, or sourced from official re...

This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by sex. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-sex.csv Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level. These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents. In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.) Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020. Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates. For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data

Please cite the following paper when using this dataset:

N. Thakur, “Five Years of COVID-19 Discourse on Instagram: A Labeled Instagram Dataset of Over Half a Million Posts for Multilingual Sentiment Analysis”, Proceedings of the 7th International Conference on Machine Learning and Natural Language Processing (MLNLP 2024), Chengdu, China, October 18-20, 2024 (Paper accepted for publication, Preprint available at: https://arxiv.org/abs/2410.03293)

Abstract

The outbreak of COVID-19 served as a catalyst for content creation and dissemination on social media platforms, as such platforms serve as virtual communities where people can connect and communicate with one another seamlessly. While there have been several works related to the mining and analysis of COVID-19-related posts on social media platforms such as Twitter (or X), YouTube, Facebook, and TikTok, there is still limited research that focuses on the public discourse on Instagram in this context. Furthermore, the prior works in this field have only focused on the development and analysis of datasets of Instagram posts published during the first few months of the outbreak. The work presented in this paper aims to address this research gap and presents a novel multilingual dataset of 500,153 Instagram posts about COVID-19 published between January 2020 and September 2024. This dataset contains Instagram posts in 161 different languages. After the development of this dataset, multilingual sentiment analysis was performed using VADER and twitter-xlm-roberta-base-sentiment. This process involved classifying each post as positive, negative, or neutral. The results of sentiment analysis are presented as a separate attribute in this dataset.

For each of these posts, the Post ID, Post Description, Date of publication, language code, full version of the language, and sentiment label are presented as separate attributes in the dataset.

The Instagram posts in this dataset are present in 161 different languages out of which the top 10 languages in terms of frequency are English (343041 posts), Spanish (30220 posts), Hindi (15832 posts), Portuguese (15779 posts), Indonesian (11491 posts), Tamil (9592 posts), Arabic (9416 posts), German (7822 posts), Italian (5162 posts), Turkish (4632 posts)

There are 535,021 distinct hashtags in this dataset with the top 10 hashtags in terms of frequency being #covid19 (169865 posts), #covid (132485 posts), #coronavirus (117518 posts), #covid_19 (104069 posts), #covidtesting (95095 posts), #coronavirusupdates (75439 posts), #corona (39416 posts), #healthcare (38975 posts), #staysafe (36740 posts), #coronavirusoutbreak (34567 posts)

The following is a description of the attributes present in this dataset

Post ID: Unique ID of each Instagram post

Post Description: Complete description of each post in the language in which it was originally published

Date: Date of publication in MM/DD/YYYY format

Language code: Language code (for example: “en”) that represents the language of the post as detected using the Google Translate API

Full Language: Full form of the language (for example: “English”) that represents the language of the post as detected using the Google Translate API

Sentiment: Results of sentiment analysis (using the preprocessed version of each post) where each post was classified as positive, negative, or neutral

Open Research Questions

This dataset is expected to be helpful for the investigation of the following research questions and even beyond:

How does sentiment toward COVID-19 vary across different languages?

How has public sentiment toward COVID-19 evolved from 2020 to the present?

How do cultural differences affect social media discourse about COVID-19 across various languages?

How has COVID-19 impacted mental health, as reflected in social media posts across different languages?

How effective were public health campaigns in shifting public sentiment in different languages?

What patterns of vaccine hesitancy or support are present in different languages?

How did geopolitical events influence public sentiment about COVID-19 in multilingual social media discourse?

What role does social media discourse play in shaping public behavior toward COVID-19 in different linguistic communities?

How does the sentiment of minority or underrepresented languages compare to that of major world languages regarding COVID-19?

What insights can be gained by comparing the sentiment of COVID-19 posts in widely spoken languages (e.g., English, Spanish) to those in less common languages?

All the Instagram posts that were collected during this data mining process to develop this dataset were publicly available on Instagram and did not require a user to log in to Instagram to view the same (at the time of writing this paper).

Overview

The Associated Press is sharing data from the COVID Impact Survey, which provides statistics about physical health, mental health, economic security and social dynamics related to the coronavirus pandemic in the United States.

Conducted by NORC at the University of Chicago for the Data Foundation, the probability-based survey provides estimates for the United States as a whole, as well as in 10 states (California, Colorado, Florida, Louisiana, Minnesota, Missouri, Montana, New York, Oregon and Texas) and eight metropolitan areas (Atlanta, Baltimore, Birmingham, Chicago, Cleveland, Columbus, Phoenix and Pittsburgh).

The survey is designed to allow for an ongoing gauge of public perception, health and economic status to see what is shifting during the pandemic. When multiple sets of data are available, it will allow for the tracking of how issues ranging from COVID-19 symptoms to economic status change over time.

The survey is focused on three core areas of research:

• Physical Health: Symptoms related to COVID-19, relevant existing conditions and health insurance coverage.
• Economic and Financial Health: Employment, food security, and government cash assistance.
• Social and Mental Health: Communication with friends and family, anxiety and volunteerism. (Questions based on those used on the U.S. Census Bureau’s Current Population Survey.) ## Using this Data - IMPORTANT This is survey data and must be properly weighted during analysis: DO NOT REPORT THIS DATA AS RAW OR AGGREGATE NUMBERS!!

Instead, use our queries linked below or statistical software such as R or SPSS to weight the data.

Queries

If you'd like to create a table to see how people nationally or in your state or city feel about a topic in the survey, use the survey questionnaire and codebook to match a question (the variable label) to a variable name. For instance, "How often have you felt lonely in the past 7 days?" is variable "soc5c".

Nationally: Go to this query and enter soc5c as the variable. Hit the blue Run Query button in the upper right hand corner.

Local or State: To find figures for that response in a specific state, go to this query and type in a state name and soc5c as the variable, and then hit the blue Run Query button in the upper right hand corner.

The resulting sentence you could write out of these queries is: "People in some states are less likely to report loneliness than others. For example, 66% of Louisianans report feeling lonely on none of the last seven days, compared with 52% of Californians. Nationally, 60% of people said they hadn't felt lonely."

Margin of Error

The margin of error for the national and regional surveys is found in the attached methods statement. You will need the margin of error to determine if the comparisons are statistically significant. If the difference is:

• At least twice the margin of error, you can report there is a clear difference.
• At least as large as the margin of error, you can report there is a slight or apparent difference.
• Less than or equal to the margin of error, you can report that the respondents are divided or there is no difference. ## A Note on Timing Survey results will generally be posted under embargo on Tuesday evenings. The data is available for release at 1 p.m. ET Thursdays.

About the Data

The survey data will be provided under embargo in both comma-delimited and statistical formats.

Each set of survey data will be numbered and have the date the embargo lifts in front of it in the format of: 01_April_30_covid_impact_survey. The survey has been organized by the Data Foundation, a non-profit non-partisan think tank, and is sponsored by the Federal Reserve Bank of Minneapolis and the Packard Foundation. It is conducted by NORC at the University of Chicago, a non-partisan research organization. (NORC is not an abbreviation, it part of the organization's formal name.)

Data for the national estimates are collected using the AmeriSpeak Panel, NORC’s probability-based panel designed to be representative of the U.S. household population. Interviews are conducted with adults age 18 and over representing the 50 states and the District of Columbia. Panel members are randomly drawn from AmeriSpeak with a target of achieving 2,000 interviews in each survey. Invited panel members may complete the survey online or by telephone with an NORC telephone interviewer.

Once all the study data have been made final, an iterative raking process is used to adjust for any survey nonresponse as well as any noncoverage or under and oversampling resulting from the study specific sample design. Raking variables include age, gender, census division, race/ethnicity, education, and county groupings based on county level counts of the number of COVID-19 deaths. Demographic weighting variables were obtained from the 2020 Current Population Survey. The count of COVID-19 deaths by county was obtained from USA Facts. The weighted data reflect the U.S. population of adults age 18 and over.

Data for the regional estimates are collected using a multi-mode address-based (ABS) approach that allows residents of each area to complete the interview via web or with an NORC telephone interviewer. All sampled households are mailed a postcard inviting them to complete the survey either online using a unique PIN or via telephone by calling a toll-free number. Interviews are conducted with adults age 18 and over with a target of achieving 400 interviews in each region in each survey.Additional details on the survey methodology and the survey questionnaire are attached below or can be found at https://www.covid-impact.org.

Attribution

Results should be credited to the COVID Impact Survey, conducted by NORC at the University of Chicago for the Data Foundation.

AP Data Distributions

​To learn more about AP's data journalism capabilities for publishers, corporations and financial institutions, go here or email kromano@ap.org.

BackgroundLong-term health conditions can affect labour market outcomes. COVID-19 may have increased labour market inequalities, e.g. due to restricted opportunities for clinically vulnerable people. Evaluating COVID-19’s impact could help target support.AimTo quantify the effect of several long-term conditions on UK labour market outcomes during the COVID-19 pandemic and compare them to pre-pandemic outcomes.MethodsThe Understanding Society COVID-19 survey collected responses from around 20,000 UK residents in nine waves from April 2020-September 2021. Participants employed in January/February 2020 with a variety of long-term conditions were matched with people without the condition but with similar baseline characteristics. Models estimated probability of employment, hours worked and earnings. We compared these results with results from a two-year pre-pandemic period. We also modelled probability of furlough and home-working frequency during COVID-19.ResultsMost conditions (asthma, arthritis, emotional/nervous/psychiatric problems, vascular/pulmonary/liver conditions, epilepsy) were associated with reduced employment probability and/or hours worked during COVID-19, but not pre-pandemic. Furlough was more likely for people with pulmonary conditions. People with arthritis and cancer were slower to return to in-person working. Few effects were seen for earnings.ConclusionCOVID-19 had a disproportionate impact on people with long-term conditions’ labour market outcomes.

A. SUMMARY Medical provider confirmed COVID-19 cases and confirmed COVID-19 related deaths in San Francisco, CA aggregated by several different geographic areas and normalized by 2016-2020 American Community Survey (ACS) 5-year estimates for population data to calculate rate per 10,000 residents. On September 12, 2021, a new case definition of COVID-19 was introduced that includes criteria for enumerating new infections after previous probable or confirmed infections (also known as reinfections). A reinfection is defined as a confirmed positive PCR lab test more than 90 days after a positive PCR or antigen test. The first reinfection case was identified on December 7, 2021. Cases and deaths are both mapped to the residence of the individual, not to where they were infected or died. For example, if one was infected in San Francisco at work but lives in the East Bay, those are not counted as SF Cases or if one dies in Zuckerberg San Francisco General but is from another county, that is also not counted in this dataset. Dataset is cumulative and covers cases going back to 3/2/2020 when testing began. Geographic areas summarized are: 1. Analysis Neighborhoods 2. Census Tracts 3. Census Zip Code Tabulation Areas B. HOW THE DATASET IS CREATED Addresses from medical data are geocoded by the San Francisco Department of Public Health (SFDPH). Those addresses are spatially joined to the geographic areas. Counts are generated based on the number of address points that match each geographic area. The 2016-2020 American Community Survey (ACS) population estimates provided by the Census are used to create a rate which is equal to ([count] / [acs_population]) * 10000) representing the number of cases per 10,000 residents. C. UPDATE PROCESS Geographic analysis is scripted by SFDPH staff and synced to this dataset daily at 7:30 Pacific Time. D. HOW TO USE THIS DATASET San Francisco population estimates for geographic regions can be found in a view based on the San Francisco Population and Demographic Census dataset. These population estimates are from the 2016-2020 5-year American Community Survey (ACS). Privacy rules in effect To protect privacy, certain rules are in effect: 1. Case counts greater than 0 and less than 10 are dropped - these will be null (blank) values 2. Death counts greater than 0 and less than 10 are dropped - these will be null (blank) values 3. Cases and deaths dropped altogether for areas where acs_population < 1000 Rate suppression in effect where counts lower than 20 Rates are not calculated unless the case count is greater than or equal to 20. Rates are generally unstable at small numbers, so we avoid calculating them directly. We advise you to apply the same approach as this is best practice in epidemiology. A note on Census ZIP Code Tabulation Areas (ZCTAs) ZIP Code Tabulation Areas are special boundaries created by the U.S. Census based on ZIP Codes developed by the USPS. They are not, however, the same thing. ZCTAs are areal representations of routes. Read how the Census develops ZCTAs on their website. Row included for Citywide case counts, incidence rate, and deaths A single row is included that has the Citywide case counts and incidence rate. This can be used for comparisons. Citywide will capture all cases regardless of address quality. While some cases cannot be mapped to sub-areas like Census Tracts, ongo

Description:

This comprehensive dataset provides global information on both COVID-19 related deaths and vaccinations from January 5, 2020, to August 4, 2024. It consists of two parts: one tracking COVID-19 cases, deaths, and population statistics, and another monitoring vaccination progress worldwide. This dataset allows for an in-depth analysis of the pandemic’s spread, fatality rates, and the effectiveness of vaccination campaigns across various countries and regions.

Researchers and data analysts can use this dataset to study trends, compare countries, and evaluate public health responses throughout the COVID-19 pandemic.

Includes:

CovidDeaths Dataset: Records of total cases, deaths, and population.

CovidVaccinations Dataset: Records of daily vaccination counts and cumulative totals.

Use Cases:

Analyzing death rates relative to confirmed cases. Examining the percentage of population affected by COVID-19. Evaluating vaccination rates and coverage across different regions. This dataset is ideal for data exploration, statistical analysis, and visualizations related to the COVID-19 pandemic.

Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that has affected millions of people worldwide. This study aims to bridge the knowledge gap between acute and chronic symptoms, vaccination impact, and associated factors in patients across different low-income countries.Methods: The study included 2,445 participants aged 18 years and older, testing positive for COVID-19. Data collection involved screening for medical histories, testing records, symptomatology, and persistent symptoms. Validated instruments, including the DePaul Symptom Questionnaire (DSQ-2) and Patient Health Questionnaire-9 (PHQ-9), were used. We applied a self-supervised and unsupervised deep neural network to extract features from the questionnaire. Gradient boosted machines (GMB) model was used to build a risk calculator for chronic fatigue, depression, and prolonged COVID-19 symptoms. The best-performing models were implemented in a shiny app and deployed online at: [https//ahmedshaheen.shinyapps.io/shaheen-covid-19/]. Also, there is an offline version of the application that can be downloaded: [link].Findings: Out of the study cohort, 69.5% of the patients had symptoms lasting longer than 2 weeks. The most frequent symptoms were loss of smell 46.8%, dry cough (40.1%), loss of taste (37.8%), headaches (37.2%), and sore throat (28.9%). The patients also reported high rates of depression (47.7%), chronic fatigue (6.5%), and infection after vaccination (24.2%). Factors associated with chronic fatigue syndrome included sex, age, and smoking. Vaccinated individuals demonstrated lower odds of experiencing prolonged COVID-19 symptoms, chronic fatigue syndrome, and depression. The predictive models achieved a high area under the receiver operating characteristic curve (AUC) scores of 0.87, 0.82, and 0.74, respectively.Interpretation: The results provide insights into the consequences of COVID-19 and a predictive tool to understand factors influencing depression, chronic fatigue syndrome, and prolonged COVID-19 symptoms. The study reveals variables affecting these outcomes and the interplay between pre-existing conditions, treatments, and the duration of symptoms post-recovery.

This dataset contains information on antibody testing for COVID-19: the number of people who received a test, the number of people with positive results, the percentage of people tested who tested positive, and the rate of testing per 100,000 people, stratified by ZIP Code Tabulation Area (ZCTA) neighborhood poverty group. These data can also be accessed here: https://github.com/nychealth/coronavirus-data/blob/master/totals/antibody-by-poverty.csv

Exposure to COVID-19 can be detected by measuring antibodies to the disease in a person’s blood, which can indicate that a person may have had an immune response to the virus. Antibodies are proteins produced by the body’s immune system that can be found in the blood. People can test positive for antibodies after they have been exposed, sometimes when they no longer test positive for the virus itself. It is important to note that the science around COVID-19 antibody tests is evolving rapidly and there is still much uncertainty about what individual antibody test results mean for a single person and what population-level antibody test results mean for understanding the epidemiology of COVID-19 at a population level.

These data only provide information on people tested. People receiving an antibody test do not reflect all people in New York City; therefore, these data may not reflect antibody prevalence among all New Yorkers. Increasing instances of screening programs further impact the generalizability of these data, as screening programs influence who and how many people are tested over time. Examples of screening programs in NYC include: employers screening their workers (e.g., hospitals), and long-term care facilities screening their residents.

In addition, there may be potential biases toward people receiving an antibody test who have a positive result because people who were previously ill are preferentially seeking testing, in addition to the testing of persons with higher exposure (e.g., health care workers, first responders.)

Neighborhood-level poverty groups were classified in a manner consistent with Health Department practices to describe and monitor disparities in health in NYC. Neighborhood poverty measures are defined as the percentage of people earning below the Federal Poverty Threshold (FPT) within a ZCTA. The standard cut-points for defining categories of neighborhood-level poverty in NYC are: • Low: <10% of residents in ZCTA living below the FPT • Medium: 10% to <20% • High: 20% to <30% • Very high: ≥30% residents living below the FPT The ZCTAs used for classification reflect the first non-missing address within NYC for each person reported with an antibody test result.

Rates were calculated using interpolated intercensal population estimates updated in 2019. These rates differ from previously reported rates based on the 2000 Census or previous versions of population estimates. The Health Department produced these population estimates based on estimates from the U.S. Census Bureau and NYC Department of City Planning. Rates for poverty were calculated using direct standardization for age at diagnosis and weighting by the US 2000 standard population. Antibody tests are categorized based on the date of specimen collection and are aggregated by full weeks starting each Sunday and ending on Saturday. For example, a person whose blood was collected for antibody testing on Wednesday, May 6 would be categorized as tested during the week ending May 9. A person tested twice in one week would only be counted once in that week. This dataset includes testing data beginning April 5, 2020.

Data are updated daily, and the dataset preserves historical records and source data changes, so each extract date reflects the current copy of the data as of that date. For example, an extract date of 11/04/2020 and extract date of 11/03/2020 will both contain all records as they were as of that extract date. Without filtering or grouping by extract date, an analysis will almost certainly be miscalculating or counting the same values multiple times. To analyze the most current data, only use the latest extract date. Antibody tests that are missing dates are not included in the dataset; as dates are identified, these events are added. Lags between occurrence and report of cases and tests can be assessed by comparing counts and rates across multiple data extract dates.

For further details, visit: • https://www1.nyc.gov/site/doh/covid/covid-19-data.page • https://github.com/nychealth/coronavirus-data • https://data.cityofnewyork.us/Health/Modified-Zip-Code-Tabulation-Areas-MODZCTA-/pri4-ifjk

The C-19GA20 dataset was gathered online in April 2020 from school and university students between 14 to 24 years of age. It provides insightful information about the students’ mental health, social lives, attitude towards Covid-19, impact of the Covid-19 Pandemic on students’ education, and their experience with online learning. The data includes 5 major groups of variables: 1) Socio-demographic data - age group, gender, current place of stay, study level in their institution 2) 4 items for information regarding connectivity to the internet during the lockdown - device availability for exclusive use, internet bandwidth, top 5 online tools used most commonly, and screen time. 3) 9 items measured the impact of Covid-19 on the students’ social lives - their current situation of living, number of people around them where they live, their feelings towards meeting their friends, visiting their institution of study, events that would have been held offline. Students were asked about their top 5 past time activities during the lockdown and the amount of time they spend on social media online. 4) 6 items to gauge their experience with online learning during the lockdown - questions about feeling connected to their peers, maintaining discipline, structured learning, and the stress/burden felt by them due to online learning in the lockdown 5) 11 items to comprehensively gather information about the students’ mental health - how well have they adapted to stay-at-home instructions, their overall mood in the lockdown, feelings towards Covid 19, their prime concerns regarding their academic schedule, being updated and informed about Covid 19, the impact of social media on their beliefs. Finally, the students were asked to write about how they feel the pandemic has changed them as a person and affected their thinking process, and the students were asked to share a one-line message for the world during the lockdown.

A. SUMMARY This dataset contains COVID-19 positive confirmed cases aggregated by several different geographic areas and by day. COVID-19 cases are mapped to the residence of the individual and shown on the date the positive test was collected. In addition, 2016-2020 American Community Survey (ACS) population estimates are included to calculate the cumulative rate per 10,000 residents. Dataset covers cases going back to 3/2/2020 when testing began. This data may not be immediately available for recently reported cases and data will change to reflect as information becomes available. Data updated daily. Geographic areas summarized are: 1. Analysis Neighborhoods 2. Census Tracts 3. Census Zip Code Tabulation Areas B. HOW THE DATASET IS CREATED Addresses from the COVID-19 case data are geocoded by the San Francisco Department of Public Health (SFDPH). Those addresses are spatially joined to the geographic areas. Counts are generated based on the number of address points that match each geographic area for a given date. The 2016-2020 American Community Survey (ACS) population estimates provided by the Census are used to create a cumulative rate which is equal to ([cumulative count up to that date] / [acs_population]) * 10000) representing the number of total cases per 10,000 residents (as of the specified date). COVID-19 case data undergo quality assurance and other data verification processes and are continually updated to maximize completeness and accuracy of information. This means data may change for previous days as information is updated. C. UPDATE PROCESS Geographic analysis is scripted by SFDPH staff and synced to this dataset daily at 05:00 Pacific Time. D. HOW TO USE THIS DATASET San Francisco population estimates for geographic regions can be found in a view based on the San Francisco Population and Demographic Census dataset. These population estimates are from the 2016-2020 5-year American Community Survey (ACS). This dataset can be used to track the spread of COVID-19 throughout the city, in a variety of geographic areas. Note that the new cases column in the data represents the number of new cases confirmed in a certain area on the specified day, while the cumulative cases column is the cumulative total of cases in a certain area as of the specified date. Privacy rules in effect To protect privacy, certain rules are in effect: 1. Any area with a cumulative case count less than 10 are dropped for all days the cumulative count was less than 10. These will be null values. 2. Once an area has a cumulative case count of 10 or greater, that area will have a new row of case data every day following. 3. Cases are dropped altogether for areas where acs_population privacy guidelines Rate suppression in effect where counts lower than 20 Rates are not calculated unless the cumulative case count is greater than or equal to 20. Rates are generally unstable at small numbers, so we avoid calculating them directly. We advise you to apply the same approach as this is best practice in epidemiology. A note on Census ZIP Code Tabulation Areas (ZCTAs) ZIP Code Tabulation Areas are spec

As global communities responded to COVID-19, we heard from public health officials that the same type of aggregated, anonymized insights we use in products such as Google Maps would be helpful as they made critical decisions to combat COVID-19. These Community Mobility Reports aimed to provide insights into what changed in response to policies aimed at combating COVID-19. The reports charted movement trends over time by geography, across different categories of places such as retail and recreation, groceries and pharmacies, parks, transit stations, workplaces, and residential.